Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 46


Steroid resistance in COPD is associated with impaired molecular chaperone Hsp90 expression by pro-inflammatory lymphocytes.

Hodge G, Roscioli E, Jersmann H, Tran HB, Holmes M, Reynolds PN, Hodge S.

Respir Res. 2016 Oct 21;17(1):135.


Cell block samples from endobronchial ultrasound transbronchial needle aspiration provide sufficient material for ancillary testing in lung cancer-a quaternary referral centre experience.

Hopkins E, Moffat D, Parkinson I, Robinson P, Jersmann H, Dougherty B, Birader MI, Francis K, Nguyen P.

J Thorac Dis. 2016 Sep;8(9):2544-2550.


The Effect of Colonization with Potentially Pathogenic Microorganisms on Efferocytosis in Chronic Obstructive Pulmonary Disease.

Hodge S, Jersmann H, Reynolds PN.

Am J Respir Crit Care Med. 2016 Oct 1;194(7):912-915. No abstract available.


Pro-phagocytic Effects of Thymoquinone on Cigarette Smoke-exposed Macrophages Occur by Modulation of the Sphingosine-1-phosphate Signalling System.

Barnawi J, Tran HB, Roscioli E, Hodge G, Jersmann H, Haberberger R, Hodge S.

COPD. 2016 Oct;13(5):653-61. doi: 10.3109/15412555.2016.1153614.


A small volume technique to examine and compare alveolar macrophage phagocytosis of apoptotic cells and non typeable Haemophilus influenzae (NTHi).

Ween M, Ahern J, Carroll A, Hodge G, Pizzutto S, Jersmann H, Reynolds P, Hodge S.

J Immunol Methods. 2016 Feb;429:7-14. doi: 10.1016/j.jim.2015.12.004.


Lymphocyte senescence in COPD is associated with decreased histone deacetylase 2 expression by pro-inflammatory lymphocytes.

Hodge G, Jersmann H, Tran HB, Roscioli E, Holmes M, Reynolds PN, Hodge S.

Respir Res. 2015 Oct 24;16:130. doi: 10.1186/s12931-015-0287-2.


Potential Link between the Sphingosine-1-Phosphate (S1P) System and Defective Alveolar Macrophage Phagocytic Function in Chronic Obstructive Pulmonary Disease (COPD).

Barnawi J, Tran H, Jersmann H, Pitson S, Roscioli E, Hodge G, Meech R, Haberberger R, Hodge S.

PLoS One. 2015 Oct 20;10(10):e0122771. doi: 10.1371/journal.pone.0122771.


Sleep Disorders in Aboriginal and Torres Strait Islander People and Residents of Regional and Remote Australia.

Woods CE, McPherson K, Tikoft E, Usher K, Hosseini F, Ferns J, Jersmann H, Antic R, Maguire GP.

J Clin Sleep Med. 2015 Nov 15;11(11):1263-71. doi: 10.5664/jcsm.5182.


Lymphocyte senescence in COPD is associated with loss of glucocorticoid receptor expression by pro-inflammatory/cytotoxic lymphocytes.

Hodge G, Jersmann H, Tran HB, Holmes M, Reynolds PN, Hodge S.

Respir Res. 2015 Jan 9;16:2. doi: 10.1186/s12931-014-0161-7.


Zinc and zinc transporters in macrophages and their roles in efferocytosis in COPD.

Hamon R, Homan CC, Tran HB, Mukaro VR, Lester SE, Roscioli E, Bosco MD, Murgia CM, Ackland ML, Jersmann HP, Lang C, Zalewski PD, Hodge SJ.

PLoS One. 2014 Oct 28;9(10):e110056. doi: 10.1371/journal.pone.0110056.


Increased CD8 T-cell granzyme B in COPD is suppressed by treatment with low-dose azithromycin.

Hodge S, Hodge G, Holmes M, Jersmann H, Reynolds PN.

Respirology. 2015 Jan;20(1):95-100. doi: 10.1111/resp.12415.


Sleep disordered breathing and polysomnography in Australia: trends in provision from 2005 to 2012 and the impact of home-based diagnosis.

Woods CE, Usher KJ, Jersmann H, Maguire GP.

J Clin Sleep Med. 2014 Jul 15;10(7):767-72. doi: 10.5664/jcsm.3868.


Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-γ by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells.

Hodge G, Barnawi J, Jurisevic C, Moffat D, Holmes M, Reynolds PN, Jersmann H, Hodge S.

Clin Exp Immunol. 2014 Oct;178(1):79-85. doi: 10.1111/cei.12392.


Targeting peripheral blood pro-inflammatory cytotoxic lymphocytes by inhibiting CD137 expression: novel potential treatment for COPD.

Hodge G, Holmes M, Jersmann H, Reynolds PN, Hodge S.

BMC Pulm Med. 2014 May 15;14:85. doi: 10.1186/1471-2466-14-85.


Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma.

Wechsler ME, Laviolette M, Rubin AS, Fiterman J, Lapa e Silva JR, Shah PL, Fiss E, Olivenstein R, Thomson NC, Niven RM, Pavord ID, Simoff M, Hales JB, McEvoy C, Slebos DJ, Holmes M, Phillips MJ, Erzurum SC, Hanania NA, Sumino K, Kraft M, Cox G, Sterman DH, Hogarth K, Kline JN, Mansur AH, Louie BE, Leeds WM, Barbers RG, Austin JH, Shargill NS, Quiring J, Armstrong B, Castro M; Asthma Intervention Research 2 Trial Study Group..

J Allergy Clin Immunol. 2013 Dec;132(6):1295-302. doi: 10.1016/j.jaci.2013.08.009.


The drug efflux pump Pgp1 in pro-inflammatory lymphocytes is a target for novel treatment strategies in COPD.

Hodge G, Holmes M, Jersmann H, Reynolds PN, Hodge S.

Respir Res. 2013 Jun 3;14:63. doi: 10.1186/1465-9921-14-63.


Defective lung macrophage function in lung cancer ± chronic obstructive pulmonary disease (COPD/emphysema)-mediated by cancer cell production of PGE2?

Dehle FC, Mukaro VR, Jurisevic C, Moffat D, Ahern J, Hodge G, Jersmann H, Reynolds PN, Hodge S.

PLoS One. 2013;8(4):e61573. doi: 10.1371/journal.pone.0061573.


Lectins offer new perspectives in the development of macrophage-targeted therapies for COPD/emphysema.

Mukaro VR, Bylund J, Hodge G, Holmes M, Jersmann H, Reynolds PN, Hodge S.

PLoS One. 2013;8(2):e56147. doi: 10.1371/journal.pone.0056147.


Increased proteinase inhibitor-9 (PI-9) and reduced granzyme B in lung cancer: mechanism for immune evasion?

Soriano C, Mukaro V, Hodge G, Ahern J, Holmes M, Jersmann H, Moffat D, Meredith D, Jurisevic C, Reynolds PN, Hodge S.

Lung Cancer. 2012 Jul;77(1):38-45. doi: 10.1016/j.lungcan.2012.01.017.


Expression profile of the sphingosine kinase signalling system in the lung of patients with chronic obstructive pulmonary disease.

Cordts F, Pitson S, Tabeling C, Gibbins I, Moffat DF, Jersmann H, Hodge S, Haberberger RV.

Life Sci. 2011 Nov 21;89(21-22):806-11. doi: 10.1016/j.lfs.2011.08.018.

Items per page

Supplemental Content

Loading ...
Support Center